To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TCEAL4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
400 supporting clones for gene TCEAL4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF314542   .a 1 to 1511 1 to 1511 exact tiling clone,   1511/1516
(99 %)
1 diff
(100.0 %id)
DW453529 Liver .a 652 to 821 17 to 186       170/186
(91 %)
6 diff
(96.8 %id)
FN143616 breast carcinoma .a 667 to 774 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
GD142017   .a 668 to 840 1 to 173       173/177
(97 %)
8 diff
(95.5 %id)
GD142018   .a 668 to 840 1 to 172       172/176
(97 %)
8 diff
(95.5 %id)
FN082369 breast carcinoma .a 711 to 766 56 to 1     Submitted on the opposite strand 56/57
(98 %)
0 diff
(100 %id)
FN130420 breast carcinoma .a 715 to 832 1 to 123       123/123
(100 %)
10 diff
(91.9 %id)
FN123804 breast carcinoma .a 717 to 811 92 to 1     Submitted on the opposite strand 92/108
(85 %)
3 diff
(97.3 %id)
FN082034 breast carcinoma .a 723 to 795 1 to 74       74/75
(98 %)
3 diff
(96.0 %id)
TI_153957315   .a 855 to 1729 77 to 943       867/1012
(85 %)
20 diff
(98.1 %id)
TI_153957340   .a 855 to 1652 74 to 868       795/1056
(75 %)
20 diff
(98.2 %id)
BQ773375 Chondrosarcoma Cell line .a 898 to 1718 838 to 19   AAA   820/821
(99 %)
5 diff
(99.4 %id)
TI_149294986   .a 907 to 1723 902 to 90   AAA   813/948
(85 %)
16 diff
(98.4 %id)
AV721982 hypothalamus .a 943 to 1671 1 to 722       722/737
(97 %)
17 diff
(97.7 %id)
BU616121 Bone, Subchondral Bone .a 952 to 1723 783 to 14   AAA   770/770
(100 %)
1 diff
(99.9 %id)
CB529555 Aveolar Macrophage, lung .a 961 to 1723 774 to 14   AAA   761/761
(100 %)
2 diff
(99.8 %id)
BM989830 lung, Lung Focal Fibrosis .a 965 to 1718 771 to 19   AAA   753/763
(98 %)
2 diff
(99.8 %id)
BG674371 skin .a 967 to 1689 1 to 723       723/969
(74 %)
14 diff
(98.6 %id)
W90269 liver and spleen .a 973 to 1305 8 to 344   fully sequenced,   337/344
(97 %)
8 diff
(97.7 %id)
AA455214 ovarian tumor, ovary .a 978 to 1335 1 to 357   fully sequenced,   357/357
(100 %)
1 diff
(99.8 %id)
R01483 liver and spleen .a 979 to 1267 1 to 294       294/329
(89 %)
16 diff
(95.2 %id)
BX104938 liver and spleen .a 982 to 1718 1 to 736   AAA   736/736
(100 %)
3 diff
(99.6 %id)
TI_149291772   .a 1035 to 1718 754 to 79   AAA   676/677
(99 %)
10 diff
(98.6 %id)
CB984738 Pooled-Glandular .a 1063 to 1716 1 to 658       658/772
(85 %)
26 diff
(96.7 %id)
BU165831 leiomyosarcoma, uterus .a 1070 to 1705 27 to 666       640/906
(70 %)
34 diff
(96.3 %id)
BM985120 lung .a 1079 to 1723 658 to 14   AAA   645/645
(100 %)
0 diff
(100 %id)
BQ028546 placenta, Placenta Choriocarcinoma .a 1080 to 1718 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
BU682184 lung .a 1098 to 1718 638 to 19   AAA   620/623
(99 %)
2 diff
(99.7 %id)
BM672458 eye, optic nerve .a 1111 to 1718 626 to 19   AAA   608/608
(100 %)
0 diff
(100 %id)
AA431913   .a 1121 to 1457 5 to 339   fully sequenced,   335/339
(98 %)
7 diff
(98.0 %id)
W02231 liver and spleen .a 1132 to 1712 1 to 581   fully sequenced,   581/581
(100 %)
17 diff
(97.1 %id)
W88911 liver and spleen .a 1132 to 1549 1 to 420   fully sequenced,   420/420
(100 %)
3 diff
(99.3 %id)
BP318555 pericardium .a 1159 to 1718 1 to 560   AAA   560/560
(100 %)
1 diff
(99.9 %id)
AA149459 uterus .a 1164 to 1278 1 to 119   fully sequenced,   119/119
(100 %)
0 diff
(100 %id)
AI681574 carcinoid, lung .a 1227 to 1719 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AW195560 pooled .a 1245 to 1724 482 to 3       480/482
(99 %)
0 diff
(100 %id)
AI818323 adenocarcinoma, Pancreas .a 1247 to 1718 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AA151611 uterus .a 1248 to 1718 477 to 1   fully sequenced,   477/477
(100 %)
7 diff
(98.6 %id)
AW024187 Kidney .a 1259 to 1718 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AI201462 Prostate .a 1261 to 1718 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AI809590 pooled .a 1272 to 1720 449 to 1       449/449
(100 %)
3 diff
(99.4 %id)
W90594 liver and spleen .a 1275 to 1718 446 to 1   fully sequenced,   446/446
(100 %)
2 diff
(99.6 %id)
AI697638 carcinoid, lung .a 1276 to 1723 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI245248 Kidney .a 1281 to 1718 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
AI076733   .a 1300 to 1718 429 to 11   AAA   419/419
(100 %)
0 diff
(100 %id)
DB533907 hippocampus .a 1305 to 1718 1 to 414     Submitted on the opposite strand 414/414
(100 %)
3 diff
(99.3 %id)
AA454873 ovarian tumor, ovary .a 1305 to 1723 419 to 1   fully sequenced,   419/419
(100 %)
0 diff
(100 %id)
AI422594 Prostate .a 1308 to 1698 393 to 1       393/393
(100 %)
2 diff
(99.5 %id)
DB529237 hippocampus .a 1336 to 1725 1 to 392     Submitted on the opposite strand 392/392
(100 %)
7 diff
(98.3 %id)
AA431111   .a 1340 to 1539 1 to 200   fully sequenced,   200/200
(100 %)
0 diff
(100 %id)
AI912850 Kidney .a 1367 to 1720 356 to 3       354/356
(99 %)
0 diff
(100 %id)
AA704778 liver and spleen .a 1371 to 1718 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
H30164 breast .a 1393 to 1719 1 to 329   AAA   329/329
(100 %)
4 diff
(98.8 %id)
R00827 liver and spleen .a 1408 to 1720 323 to 1       323/360
(89 %)
16 diff
(95.6 %id)
AA693392 parathyroid gland, parathyroid tumor .a 1415 to 1729 318 to 4       315/318
(99 %)
0 diff
(100 %id)
D79967 aorta .a 1416 to 1718 1 to 301       301/301
(100 %)
5 diff
(98.4 %id)
N73975 liver and spleen .a 1425 to 1718 295 to 1   fully sequenced,   295/295
(100 %)
0 diff
(100 %id)
AA443700   .a 1427 to 1718 292 to 1   fully sequenced,   292/292
(100 %)
0 diff
(100 %id)
CN277653 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1452 to 1718 1 to 268   AAA   268/268
(100 %)
1 diff
(99.7 %id)
AA904452 pooled .a 1452 to 1719 268 to 1       268/268
(100 %)
1 diff
(99.7 %id)
DA737978   .a 1460 to 1718 2 to 260   fully sequenced, capped   259/259
(100 %)
0 diff
(100 %id)
AW150406 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1495 to 1727 250 to 18   AAA   233/242
(96 %)
3 diff
(98.8 %id)
BM672437 eye, optic nerve .a 1496 to 1718 241 to 19   AAA   223/223
(100 %)
0 diff
(100 %id)
AA877435 pooled germ cell tumors .a 1502 to 1718 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AA432125   .a 1509 to 1727 219 to 1   tiling clone, fully sequenced,   219/219
(100 %)
0 diff
(100 %id)
W88790 liver and spleen .a 1519 to 1720 206 to 1   fully sequenced,   206/206
(100 %)
0 diff
(100 %id)
DB370594   .a 1643 to 1718 76 to 1   fully sequenced,   76/76
(100 %)
0 diff
(100 %id)
DA270513 caudate nucleus .b-u 1 to 407 2 to 412   tiling clone, capped   411/411
(100 %)
5 diff
(98.8 %id)
AK093021 Spleen .b-u 18 to 2027 1 to 2010   tiling clone, available from FLJ,   2010/2010
(100 %)
0 diff
(100 %id)
AX747862   .b-u 18 to 2027 1 to 2010       2010/2010
(100 %)
0 diff
(100 %id)
DA944781 Spleen .b-u 19 to 579 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB169059 kidney, tumor tissue .b-u 27 to 589 2 to 569   capped   568/568
(100 %)
6 diff
(99.0 %id)
DA135276 alzheimer cortex .b-u 34 to 586 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
DA832043 placenta .b-u 35 to 695 2 to 662   capped   661/661
(100 %)
4 diff
(99.4 %id)
DA041610 bladder .b-u 937 to 1496 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA041637 bladder .b-u 937 to 1460 2 to 526   capped   525/525
(100 %)
3 diff
(99.5 %id)
AL110464 uterus .b-u 1070 to 1674 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
DB378009 placenta .b-u 1456 to 2023 570 to 1       570/572
(99 %)
26 diff
(95.5 %id)
DB333446 Spleen .b-u 1483 to 2027 545 to 1       545/545
(100 %)
0 diff
(100 %id)
BI084326 epidermoid carcinoma, cell line, salivary gland .c 1 to 467 1 to 468   tiling clone, fully sequenced,   468/468
(100 %)
1 diff
(99.8 %id)
DW454937 Liver .c 3 to 162 18 to 178       161/178
(90 %)
7 diff
(96.1 %id)
BI084653 epidermoid carcinoma, cell line, salivary gland .c 437 to 965 531 to 1   tiling clone, fully sequenced,   531/531
(100 %)
13 diff
(97.6 %id)
CF272341 Brain glioblastoma .d 1 to 869 1 to 876 K83E M84I K85E N86D H88P ... tiling clone,   876/906
(96 %)
19 diff
(98.0 %id)
BX433044 brain, fetal brain .d 211 to 960 758 to 1 exact tiling clone,   758/1013
(74 %)
20 diff
(98.1 %id)
AU253367 neuroblastoma .e 1 to 641 1 to 642 exact tiling clone, fully sequenced,   642/642
(100 %)
1 diff
(99.9 %id)
AU253368 neuroblastoma .e 600 to 1291 700 to 17   tiling clone, fully sequenced, AAA   684/684
(100 %)
13 diff
(98.1 %id)
AL833640 human endometrium carcinoma cell line .f 1 to 1133 1 to 1133 exact tiling clone, available from DKFZ, AAA   1133/1133
(100 %)
2 diff
(99.9 %id)
NM_024863.4   .f 1 to 1343 1 to 1343 exact RefSeq, AAA   1343/1343
(100 %)
0 diff
(100 %id)
BE616754 adenocarcinoma, Pancreas .f 63 to 794 14 to 753 V12F S14A A15L L16C R17E ...     740/753
(98 %)
23 diff
(97.0 %id)
BE616534 adenocarcinoma, Pancreas .f 63 to 842 37 to 797 V12F S14A A15L L16C R17E ...     761/1032
(73 %)
35 diff
(96.7 %id)
BE615910 adenocarcinoma, Pancreas .f 81 to 842 1 to 753 exact     753/957
(78 %)
19 diff
(98.1 %id)
BF359447 lung_tumor .f 125 to 456 15 to 339 Q32K E33G K34G G36I K37S ...     325/352
(92 %)
9 diff
(97.5 %id)
CR594284 fetal brain .g 1 to 1571 1 to 1571 exact tiling clone,   1571/1571
(100 %)
0 diff
(100 %id)
AL537033 brain, fetal brain .g 1 to 788 1 to 808 A20X S29X A30E K42Q P43D ... fully sequenced,   777/777
(100 %)
35 diff
(95.5 %id)
DA843181 placenta .g 169 to 712 2 to 545 exact capped   544/544
(100 %)
0 diff
(100 %id)
TI_57188555   .g 369 to 940 54 to 623       575/570
(100 %)
9 diff
(98.5 %id)
BI856606 breast, mammary adenocarcinoma, cell line .g 370 to 940 1 to 569       574/569
(100 %)
9 diff
(98.5 %id)
BF592216 breast, lobullar carcinoma in situ .g 400 to 744 362 to 1       379/362
(104 %)
60 diff
(83.5 %id)
CK430927 eye, lacrimal gland .g 416 to 1018 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BQ306899 breast .g 429 to 1017 601 to 17       585/601
(97 %)
2 diff
(99.7 %id)
AL537032 brain, fetal brain .g 758 to 1259 812 to 310   fully sequenced,   503/503
(100 %)
31 diff
(93.9 %id)
BU536419 mixed (pool of 40 RNAs) .h 1 to 387 4 to 390   tiling clone, AAA   390/390
(100 %)
4 diff
(99.0 %id)
DA191277 amygdala .h 1 to 584 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
NM_001006935.1   .h 1 to 1284 1 to 1284 exact RefSeq, AAA   1284/1284
(100 %)
0 diff
(100 %id)
AK024827   .h 2 to 1074 1 to 1073 R157G available from FLJ, AAA   1073/1073
(100 %)
4 diff
(99.7 %id)
AK225117 coronary artery .h 2 to 1074 1 to 1073 R157G AAA   1073/1073
(100 %)
4 diff
(99.7 %id)
BP207475 coronary artery .h 2 to 582 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP211069 cerebellum .h 2 to 491 1 to 489       489/500
(97 %)
6 diff
(98.8 %id)
BP212708 cerebrum .h 2 to 567 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
BP213948 cerebrum .h 2 to 580 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BU506689 mixed (pool of 40 RNAs) .h 6 to 603 1 to 608       608/909
(66 %)
33 diff
(96.4 %id)
CD700101 normal nasopharynx .h 9 to 374 17 to 382       366/382
(95 %)
6 diff
(98.5 %id)
BP346619 brain .h 12 to 590 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA226025 brain .h 13 to 569 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
CB125877 Liver .h 16 to 479 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
BU942365 mixed (pool of 40 RNAs) .h 17 to 385 1 to 372       372/378
(98 %)
6 diff
(98.5 %id)
CD691067 normal nasopharynx .h 18 to 454 32 to 468       437/468
(93 %)
8 diff
(98.3 %id)
CN259217 embryonic stem cells, DMSO-treated H9 cellline .h 18 to 721 1 to 704       704/704
(100 %)
3 diff
(99.6 %id)
BG677026 skin, squamous cell carcinoma .h 18 to 934 1 to 938 K3*     938/938
(100 %)
67 diff
(92.9 %id)
BX477611   .h 19 to 589 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
DW467598 Liver .h 20 to 347 18 to 345       328/345
(95 %)
7 diff
(98.0 %id)
BQ428112 leiomyosarcoma, uterus .h 20 to 506 1 to 493       493/692
(71 %)
16 diff
(97.7 %id)
BP211632 cerebrum .h 21 to 602 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ640569 eye, retina .h 21 to 580 1 to 560       560/560
(100 %)
18 diff
(96.8 %id)
CB107511 Liver .h 21 to 427 1 to 407       407/407
(100 %)
0 diff
(100 %id)
BP346598 brain .h 21 to 603 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AA359266 lung .h 23 to 339 1 to 314       314/314
(100 %)
3 diff
(99.1 %id)
AF271783 Pituitary .h 23 to 1284 1 to 1262 exact tiling clone, AAA   1262/1262
(100 %)
0 diff
(100 %id)
BP228061   .h 23 to 478 1 to 456       456/569
(80 %)
16 diff
(97.2 %id)
BU596527 mixed (pool of 40 RNAs) .h 24 to 449 1 to 426       426/426
(100 %)
4 diff
(99.1 %id)
BU861133 mixed (pool of 40 RNAs) .h 24 to 420 1 to 397       397/431
(92 %)
5 diff
(98.9 %id)
DW418329 Liver .h 25 to 438 18 to 431       414/431
(96 %)
10 diff
(97.7 %id)
DW432007 Liver .h 25 to 272 20 to 267       248/267
(92 %)
7 diff
(97.4 %id)
DW442474 Liver .h 25 to 238 18 to 232       215/234
(91 %)
8 diff
(96.6 %id)
DW446378 Liver .h 25 to 224 18 to 217       200/217
(92 %)
6 diff
(97.3 %id)
AA373711 lung .h 26 to 227 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
DW428951 Liver .h 27 to 283 18 to 274       257/274
(93 %)
7 diff
(97.5 %id)
DW439312 Liver .h 27 to 248 20 to 242       223/242
(92 %)
8 diff
(96.7 %id)
DW440548 Liver .h 27 to 395 18 to 386       369/386
(95 %)
7 diff
(98.2 %id)
BP232573 muscle .h 27 to 603 1 to 577       577/586
(98 %)
2 diff
(99.7 %id)
DW411174 Liver .h 28 to 345 13 to 330       318/330
(96 %)
7 diff
(97.9 %id)
DW434007 Liver .h 28 to 275 13 to 260       248/260
(95 %)
6 diff
(97.7 %id)
DW434875 Liver .h 28 to 272 13 to 257       245/257
(95 %)
8 diff
(96.9 %id)
DW445293 Liver .h 28 to 236 13 to 222       210/222
(94 %)
7 diff
(96.9 %id)
CN259216 embryonic stem cells, cell lines H1, H7, andH9 .h 31 to 297 6 to 272       267/272
(98 %)
6 diff
(97.8 %id)
CN259220 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 32 to 784 1 to 753       753/753
(100 %)
2 diff
(99.8 %id)
BM852842 Ascites, stomach .h 32 to 479 1 to 448       448/448
(100 %)
1 diff
(99.8 %id)
DT217208 brain .h 35 to 702 1 to 668       668/668
(100 %)
2 diff
(99.8 %id)
DB466991 hippocampus .h 35 to 451 1 to 417       417/417
(100 %)
1 diff
(99.8 %id)
BP321130 placenta .h 35 to 617 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BC012296 Placenta, choriocarcinoma .h 36 to 1074 1 to 1039 K132T available from MGC, AAA   1039/1039
(100 %)
2 diff
(99.9 %id)
BQ949973 epidermoid carcinoma, cell line, lung .h 36 to 984 1 to 960 A178G F179V L180F W181G M182G ...     960/960
(100 %)
24 diff
(97.5 %id)
AL702455 human skeletal muscle .h 38 to 425 1 to 388       388/389
(99 %)
2 diff
(99.5 %id)
BF896770 marrow .h 39 to 424 388 to 2     Submitted on the opposite strand 387/388
(99 %)
0 diff
(100 %id)
BF930478 nervous_tumor .h 39 to 361 329 to 4     Submitted on the opposite strand 326/329
(99 %)
0 diff
(100 %id)
BI088252 cervix .h 39 to 707 1 to 669       669/670
(99 %)
13 diff
(98.1 %id)
BP348643 brain .h 39 to 620 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BF896772 marrow .h 40 to 428 404 to 16     Submitted on the opposite strand 395/405
(97 %)
0 diff
(100 %id)
CN259215 embryonic stem cells, DMSO-treated H9 cellline .h 42 to 302 1 to 261       261/261
(100 %)
0 diff
(100 %id)
BU532519 mixed (pool of 40 RNAs) .h 42 to 450 1 to 409       409/438
(93 %)
3 diff
(99.4 %id)
BU557717 adenocarcinoma, cell line, breast .h 42 to 690 1 to 657       657/1092
(60 %)
22 diff
(98.0 %id)
BP194281 brain .h 43 to 624 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BG290113 bladder, transitional cell papilloma, cell line .h 43 to 679 1 to 644       644/644
(100 %)
20 diff
(96.9 %id)
BU956293 adenocarcinoma, cell line, breast .h 43 to 874 1 to 837       837/943
(88 %)
20 diff
(97.9 %id)
BM552246 leiomyosarcoma, uterus .h 45 to 971 1 to 939 D188G P195S R196Q E197G F198I ...     939/1022
(91 %)
21 diff
(98.0 %id)
DA241559 brain .h 46 to 646 2 to 604   capped   603/603
(100 %)
2 diff
(99.7 %id)
BM698357 eye, fetal eyes .h 46 to 444 1 to 399       399/399
(100 %)
0 diff
(100 %id)
DW414314 Liver .h 48 to 347 17 to 316       300/316
(94 %)
7 diff
(97.8 %id)
DW414594 Liver .h 48 to 346 17 to 315       299/315
(94 %)
9 diff
(97.2 %id)
DW415215 Liver .h 48 to 344 17 to 313       297/313
(94 %)
9 diff
(97.2 %id)
BQ712335 Spleen .h 48 to 1013 1 to 953 L36V D160X N161H K171X S172A ...     953/956
(99 %)
22 diff
(97.7 %id)
BQ073394 epidermoid carcinoma, cell line, lung .h 49 to 950 1 to 916 Q174R G177R R184E N185I L186Y ...     916/992
(92 %)
32 diff
(96.8 %id)
BQ441545 testis .h 50 to 518 1 to 469       469/870
(53 %)
14 diff
(98.4 %id)
CK001987 brain/CNS, Bulk tissue from Human Spinal cord .h 50 to 679 1 to 623       623/664
(93 %)
11 diff
(98.4 %id)
CN259219 embryonic stem cells, cell lines H1, H7, andH9 .h 51 to 773 1 to 722       722/722
(100 %)
3 diff
(99.6 %id)
BM563679 astrocytoma grade IV, cell line, brain .h 53 to 918 1 to 879 S172A K173N Q174R K175N L176W ...     879/1028
(85 %)
18 diff
(98.3 %id)
DA824921 pericardium .h 54 to 620 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BE563405 adenocarcinoma, Pancreas .h 55 to 952 1 to 881 S108V E109K T110Q R111G A112L ...     881/884
(99 %)
28 diff
(96.9 %id)
BE531125 adenocarcinoma, Pancreas .h 56 to 818 1 to 755       755/875
(86 %)
16 diff
(98.2 %id)
AA149421 uterus .h 57 to 428 1 to 366       371/369
(100 %)
10 diff
(97.3 %id)
BE535231 cervix .h 57 to 848 1 to 782       782/991
(78 %)
24 diff
(97.6 %id)
BM423965 amelanotic melanoma, cell line, skin .h 57 to 998 1 to 950 K171X E197G F198I R199Q G201W ...     950/1017
(93 %)
19 diff
(98.2 %id)
BU178719 leiomyosarcoma, uterus .h 57 to 776 1 to 728       728/796
(91 %)
24 diff
(97.0 %id)
CN259218 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 58 to 227 1 to 170       170/170
(100 %)
0 diff
(100 %id)
AI879268 brain, frontal lobe .h 58 to 605 35 to 582       548/582
(94 %)
6 diff
(99.0 %id)
BM810834 amelanotic melanoma, cell line, skin .h 58 to 908 1 to 862 E168X R184K G194R P195S R196K ...     862/1079
(79 %)
13 diff
(98.8 %id)
BU845229 ovary, teratocarcinoma, cell line .h 62 to 1008 1 to 957 S172A K173N Q174R K175N L176W ...     957/958
(99 %)
21 diff
(97.9 %id)
CD708632 normal nasopharynx .h 63 to 294 10 to 241       232/241
(96 %)
8 diff
(96.7 %id)
BG425947 Kidney .h 63 to 726 1 to 670       670/783
(85 %)
31 diff
(96.1 %id)
CX871420 embryonic stem .h 63 to 812 1 to 750       750/750
(100 %)
0 diff
(100 %id)
CD241988 Blood vessels - aorta, basilar and artery .h 63 to 622 1 to 566       571/868
(65 %)
25 diff
(97.2 %id)
BG482671 lung .h 64 to 360 1 to 295       295/297
(99 %)
3 diff
(99.0 %id)
BU599075 mixed (pool of 40 RNAs) .h 65 to 671 1 to 607       607/612
(99 %)
5 diff
(99.2 %id)
BF679018 Prostate .h 67 to 378 1 to 311       311/675
(46 %)
9 diff
(98.7 %id)
BG034388 breast, mammary adenocarcinoma, cell line .h 67 to 877 24 to 831       808/1008
(80 %)
43 diff
(95.8 %id)
BG430876 Kidney .h 67 to 767 1 to 710       710/761
(93 %)
10 diff
(98.7 %id)
AA094502   .h 68 to 308 1 to 236       236/236
(100 %)
5 diff
(97.9 %id)
AA094991   .h 68 to 292 1 to 221       221/226
(97 %)
5 diff
(97.8 %id)
DW413592 Liver .h 68 to 365 19 to 319       301/319
(94 %)
8 diff
(97.5 %id)
BG290593 bladder, transitional cell papilloma, cell line .h 69 to 765 1 to 697       697/707
(98 %)
7 diff
(99.1 %id)
AA302734 adipose tissue, white .h 70 to 356 9 to 293       285/293
(97 %)
11 diff
(96.3 %id)
BE783119 eye, retinoblastoma .h 70 to 786 1 to 716       716/716
(100 %)
4 diff
(99.5 %id)
BX388070   .h 73 to 1080 1 to 1000 E103*     1005/1003
(100 %)
15 diff
(98.6 %id)
BE278328 choriocarcinoma, placenta .h 74 to 748 9 to 682       674/712
(94 %)
20 diff
(97.2 %id)
DN992285 brain, whole brain .h 74 to 662 1 to 589       589/589
(100 %)
6 diff
(99.0 %id)
BU781903 insulinoma, Pancreas .h 75 to 662 1 to 588       588/588
(100 %)
6 diff
(99.0 %id)
AA626097 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 79 to 400 322 to 1       322/322
(100 %)
2 diff
(99.4 %id)
BF724141 eye, Iris .h 80 to 467 1 to 388       388/388
(100 %)
0 diff
(100 %id)
BE297516 muscle, rhabdomyosarcoma .h 82 to 751 1 to 657       657/759
(86 %)
27 diff
(96.5 %id)
BF203563 muscle, rhabdomyosarcoma .h 86 to 817 1 to 734       734/968
(75 %)
40 diff
(95.9 %id)
BF205883 muscle, rhabdomyosarcoma .h 86 to 770 1 to 681       681/687
(99 %)
13 diff
(98.2 %id)
BG422375 Kidney, renal cell adenocarcinoma .h 93 to 768 1 to 667       667/932
(71 %)
14 diff
(98.5 %id)
BQ308838 breast .h 94 to 344 249 to 1       249/250
(99 %)
13 diff
(94.8 %id)
BE700058 nervous_normal .h 97 to 328 284 to 57       233/284
(82 %)
0 diff
(100 %id)
BI032589 nervous_normal .h 107 to 547 448 to 9       440/448
(98 %)
1 diff
(99.8 %id)
BF592677 breast, lobullar carcinoma in situ .h 108 to 441 16 to 344     Submitted on the opposite strand 334/354
(94 %)
14 diff
(96.1 %id)
BF844380 head_neck .h 128 to 500 381 to 9     Submitted on the opposite strand 373/385
(96 %)
5 diff
(98.8 %id)
AV749733 Pituitary .h 155 to 497 1 to 334       334/334
(100 %)
4 diff
(98.9 %id)
AA328041   .h 159 to 463 1 to 303       303/304
(99 %)
4 diff
(98.7 %id)
AV750279 Pituitary .h 166 to 690 1 to 514       514/519
(99 %)
17 diff
(96.8 %id)
AW674108 cervix .h 181 to 532 1 to 355       355/355
(100 %)
3 diff
(99.2 %id)
BX440364 brain, fetal brain .h 194 to 1051 857 to 1 K3X Y5X S6X E7X N8X ...     857/958
(89 %)
18 diff
(98.2 %id)
TI_149291630   .h 213 to 1077 938 to 83 E2K K3T L4X Y5S S6E ...     856/995
(86 %)
0 diff
(100 %id)
BU736112 eye, fetal eyes .h 744 to 1075 351 to 19   AAA   333/333
(100 %)
5 diff
(98.5 %id)
AI879651 brain, frontal lobe .h 855 to 1293 452 to 14   AAA   439/439
(100 %)
0 diff
(100 %id)
AA149307 uterus .h 989 to 1293 309 to 1       576/626
(92 %)
36 diff
(94.3 %id)
BI259663 cervical carcinoma cell line, cervix .h 1074 to 1293 1 to 218   AAA   218/218
(100 %)
2 diff
(99.1 %id)
AI080340 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1085 to 1284 200 to 1       200/200
(100 %)
0 diff
(100 %id)
DA230626 brain .i 1 to 568 7 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
NM_001006937.1   .i 1 to 1279 1 to 1279 exact RefSeq, AAA   1279/1279
(100 %)
0 diff
(100 %id)
BP375855 uterus .i 2 to 562 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
FN117189 breast carcinoma .i 24 to 100 1 to 77       77/81
(95 %)
3 diff
(96.3 %id)
DW431917 Liver .i 25 to 270 18 to 267       250/267
(93 %)
6 diff
(97.8 %id)
FN050118 breast carcinoma .i 27 to 119 93 to 1     Submitted on the opposite strand 93/94
(98 %)
0 diff
(100 %id)
FN081838 breast carcinoma .i 28 to 137 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
FN097483 breast carcinoma .i 28 to 133 104 to 1     Submitted on the opposite strand 104/108
(96 %)
3 diff
(97.3 %id)
FN078935 breast carcinoma .i 29 to 106 1 to 78       78/78
(100 %)
1 diff
(98.8 %id)
DW454205 Liver .i 39 to 203 18 to 182       165/182
(90 %)
6 diff
(96.8 %id)
DW432175 Liver .i 61 to 316 11 to 266       256/266
(96 %)
7 diff
(97.4 %id)
FN147273 breast carcinoma .i 70 to 173 103 to 1     Submitted on the opposite strand 103/103
(100 %)
1 diff
(99.1 %id)
DB463375 hippocampus .i 74 to 514 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
BM352963 Pancreas, Purified pancreatic islet .i 119 to 606 1 to 488       488/488
(100 %)
6 diff
(98.8 %id)
CK821928 Pancreas, Purified pancreatic islet .i 128 to 324 1 to 197     Submitted on the opposite strand 197/197
(100 %)
0 diff
(100 %id)
TI_59391796   .i 208 to 1069 109 to 965 F179Y L180S W181G M182C Q183K ... AAA   857/857
(100 %)
14 diff
(98.4 %id)
BM013858 breast, mammary adenocarcinoma, cell line .i 210 to 1072 1 to 858 F179Y L180S W181G M182C Q183K ...     858/929
(92 %)
15 diff
(98.4 %id)
AW580741 leiomios .i 212 to 537 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
TI_1948072304   .i 218 to 411 130 to 323   fully sequenced,   194/210
(92 %)
6 diff
(97.2 %id)
TI_1948071982   .i 219 to 568 117 to 465     Submitted on the opposite strand 349/366
(95 %)
6 diff
(98.4 %id)
TI_1948072138   .i 220 to 447 126 to 353       228/246
(92 %)
6 diff
(97.6 %id)
TI_1948072473   .i 220 to 487 127 to 394       268/286
(93 %)
6 diff
(98.0 %id)
BI388679 bone marrow .i 229 to 508 291 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 280/291
(96 %)
0 diff
(100 %id)
CV024890 mixed .i 230 to 867 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BX412608 brain, fetal brain .i 232 to 977 761 to 1       761/800
(95 %)
50 diff
(93.8 %id)
BF799458 colon_ins .i 234 to 481 1 to 247       247/247
(100 %)
7 diff
(97.2 %id)
TI_154130936   .i 266 to 1072 876 to 81       796/1066
(74 %)
0 diff
(100 %id)
FN112316 breast carcinoma .i 297 to 415 1 to 117       117/120
(97 %)
4 diff
(96.7 %id)
TI_149285289   .i 304 to 1072 856 to 96       761/895
(85 %)
0 diff
(100 %id)
BG288266 bladder, transitional cell papilloma, cell line .i 309 to 1023 1 to 710       710/712
(99 %)
10 diff
(98.6 %id)
FN176636 breast carcinoma .i 328 to 407 79 to 4     Submitted on the opposite strand 76/80
(95 %)
0 diff
(100 %id)
BQ640475 eye, retina .i 369 to 974 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
BM974147 lung .i 369 to 1069 719 to 19   AAA   701/701
(100 %)
1 diff
(99.9 %id)
BG034634 breast, mammary adenocarcinoma, cell line .i 377 to 1069 1 to 696   AAA   696/696
(100 %)
10 diff
(98.6 %id)
TI_1948072305   .i 381 to 882 618 to 117   fully sequenced,   502/618
(81 %)
6 diff
(99.1 %id)
CA417958 Bone, Human Chondrosarcoma Cell Line .i 388 to 1069 700 to 19   AAA   682/682
(100 %)
2 diff
(99.8 %id)
CK023822 brain/CNS, Human Brain - Cerebellar Cortex .i 393 to 1029 1 to 631       631/726
(86 %)
17 diff
(97.7 %id)
BI913032 brain .i 403 to 1059 1 to 659       659/720
(91 %)
10 diff
(98.7 %id)
TI_57238555   .i 403 to 1059 1 to 659       659/794
(82 %)
10 diff
(98.8 %id)
BM712184 eye, lens .i 404 to 718 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
TI_57193394   .i 406 to 1067 52 to 716       665/745
(89 %)
12 diff
(98.4 %id)
BG288140 bladder, transitional cell papilloma, cell line .i 407 to 1072 1 to 667       667/698
(95 %)
2 diff
(99.8 %id)
BI861902 breast, mammary adenocarcinoma, cell line .i 407 to 1072 1 to 669   AAA   669/669
(100 %)
14 diff
(98.0 %id)
TI_149272995   .i 409 to 1072 740 to 77       664/965
(68 %)
0 diff
(100 %id)
BM686437 eye, eye anterior segment .i 416 to 1132 9 to 725   tiling clone,   717/725
(98 %)
6 diff
(99.2 %id)
BM686461 eye, eye anterior segment .i 416 to 1090 9 to 683       675/683
(98 %)
6 diff
(99.2 %id)
BM798160 Ascites, stomach .i 422 to 873 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
BU626381 Bone, Subchondral Bone .i 425 to 1069 663 to 19   AAA   645/660
(97 %)
2 diff
(99.7 %id)
AW887412 ovary .i 433 to 729 1 to 298       298/298
(100 %)
10 diff
(96.7 %id)
TI_149287356   .i 433 to 1072 707 to 69       639/1176
(54 %)
0 diff
(100 %id)
BM972690 lung .i 433 to 1069 654 to 19   AAA   636/644
(98 %)
2 diff
(99.7 %id)
BG029974 breast, mammary adenocarcinoma, cell line .i 435 to 1071 1 to 637   AAA   637/637
(100 %)
2 diff
(99.7 %id)
BQ772971 Chondrosarcoma Cell line .i 438 to 1069 650 to 19   AAA   632/632
(100 %)
2 diff
(99.7 %id)
BM984817 lung .i 441 to 1069 646 to 19   AAA   628/628
(100 %)
3 diff
(99.6 %id)
BM696340 eye, lens .i 441 to 1046 1 to 606   fully sequenced,   606/606
(100 %)
2 diff
(99.7 %id)
BU675466 lung, Primary Lung Epithelial Cells .i 446 to 1069 642 to 19   AAA   624/624
(100 %)
0 diff
(100 %id)
AA304698 aorta .i 474 to 811 1 to 344       344/344
(100 %)
9 diff
(97.4 %id)
AW958064   .i 475 to 1071 1 to 597   AAA   597/597
(100 %)
7 diff
(98.9 %id)
CK001804 brain/CNS, Bulk tissue from Human Spinal cord .i 490 to 1125 1 to 635       635/635
(100 %)
4 diff
(99.4 %id)
TI_149276852   .i 492 to 1072 661 to 81       581/662
(87 %)
0 diff
(100 %id)
BM824430 Ascites, stomach .i 496 to 921 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
BU071905 insulinoma, Pancreas .i 497 to 1069 1 to 573   fully sequenced, AAA   573/573
(100 %)
4 diff
(99.4 %id)
BU615488 Bone, Enchondroma cell line .i 501 to 1069 587 to 19   AAA   569/569
(100 %)
1 diff
(99.9 %id)
R05731 liver and spleen .i 504 to 766 1 to 266       266/266
(100 %)
10 diff
(96.3 %id)
CB135358 Liver .i 509 to 806 1 to 298       298/298
(100 %)
0 diff
(100 %id)
CB242848 Human Lung Epithelial cells, lung .i 509 to 1069 579 to 19   AAA   561/574
(97 %)
0 diff
(100 %id)
BE172619 head_neck .i 510 to 721 27 to 236       210/236
(88 %)
6 diff
(97.5 %id)
TI_149275836   .i 514 to 1069 649 to 94   AAA   556/975
(57 %)
4 diff
(99.6 %id)
BU676866 lung, Primary Lung Epithelial Cells .i 514 to 1069 574 to 19   AAA   556/560
(99 %)
4 diff
(99.3 %id)
BQ787491 insulinoma, Pancreas .i 515 to 1019 1 to 505       505/505
(100 %)
4 diff
(99.3 %id)
BU069609 insulinoma, Pancreas .i 515 to 1054 1 to 540       540/540
(100 %)
4 diff
(99.3 %id)
BM706774 eye, optic nerve .i 517 to 1069 6 to 558   fully sequenced, AAA   553/558
(99 %)
6 diff
(99.0 %id)
AA226633   .i 518 to 846 1 to 331       331/335
(98 %)
6 diff
(98.3 %id)
BI496237 cochlea, ear .i 518 to 1066 8 to 556       549/556
(98 %)
6 diff
(99.0 %id)
CA438981 lung, Lung Focal Fibrosis .i 520 to 1041 544 to 23   AAA   522/529
(98 %)
0 diff
(100 %id)
AA225440   .i 521 to 1014 1 to 504       504/515
(97 %)
15 diff
(97.1 %id)
BU781840 insulinoma, Pancreas .i 521 to 1069 1 to 549   fully sequenced, AAA   549/549
(100 %)
5 diff
(99.1 %id)
BU781925 insulinoma, Pancreas .i 521 to 1069 1 to 549   fully sequenced, AAA   549/549
(100 %)
5 diff
(99.1 %id)
AA057267 uterus .i 522 to 730 1 to 209   fully sequenced,   209/209
(100 %)
1 diff
(99.6 %id)
BE890624 melanotic melanoma, skin .i 524 to 1067 1 to 551       551/568
(97 %)
18 diff
(96.9 %id)
EC536098 Prostate .i 529 to 635 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BU951801 Pancreas, Purified pancreatic islet .i 529 to 1069 541 to 1       541/549
(98 %)
19 diff
(96.6 %id)
TI_44345503   .i 532 to 1137 79 to 684       606/684
(88 %)
6 diff
(99.2 %id)
BI668798 brain, hypothalamus .i 535 to 1137 1 to 603       603/603
(100 %)
9 diff
(98.6 %id)
AA225488   .i 537 to 1072 537 to 1       537/539
(99 %)
3 diff
(99.5 %id)
TI_159723729   .i 539 to 1069 645 to 115   AAA   531/978
(54 %)
6 diff
(99.4 %id)
CA945234 Human Lung Epithelial cells, lung .i 539 to 1069 545 to 15   AAA   531/561
(94 %)
6 diff
(99.0 %id)
TI_1948072474   .i 542 to 876 461 to 127       335/362
(92 %)
0 diff
(100 %id)
BM474100 leiomyosarcoma, uterus .i 547 to 1069 1 to 523   AAA   523/523
(100 %)
1 diff
(99.9 %id)
BQ013920 placenta .i 547 to 1069 540 to 18   AAA   523/523
(100 %)
3 diff
(99.5 %id)
BM969000 lung, Primary Lung Epithelial Cells .i 547 to 1069 541 to 19   AAA   523/523
(100 %)
0 diff
(100 %id)
BF822338 kidney_tumor .i 550 to 943 1 to 394       394/394
(100 %)
6 diff
(98.5 %id)
BF822337 kidney_tumor .i 556 to 943 4 to 390       387/390
(99 %)
6 diff
(98.5 %id)
FN107789 breast carcinoma .i 556 to 664 105 to 1     Submitted on the opposite strand 105/106
(99 %)
4 diff
(96.3 %id)
TI_1948072139   .i 559 to 876 445 to 128       318/345
(92 %)
0 diff
(100 %id)
FN100401 breast carcinoma .i 560 to 653 93 to 1     Submitted on the opposite strand 93/106
(87 %)
3 diff
(97.2 %id)
FN055358 breast carcinoma .i 562 to 667 1 to 107       107/108
(99 %)
3 diff
(97.3 %id)
AI910566 pooled .i 563 to 975 13 to 425     Submitted on the opposite strand 413/425
(97 %)
7 diff
(98.4 %id)
AA187430   .i 580 to 1045 1 to 464       464/469
(98 %)
4 diff
(99.2 %id)
BM746158 stomach .i 591 to 1038 1 to 448       448/448
(100 %)
0 diff
(100 %id)
FN053796 breast carcinoma .i 593 to 665 1 to 70       70/71
(98 %)
4 diff
(94.4 %id)
BM988478 lung, Metastatic Chondrosarcoma .i 593 to 1069 495 to 19   AAA   477/485
(98 %)
1 diff
(99.8 %id)
BE222596 brain, oligodendroglioma .i 594 to 1069 487 to 12   AAA   476/476
(100 %)
1 diff
(99.8 %id)
AW192374 adenocarcinoma, Pancreas .i 608 to 1072 471 to 7       465/471
(98 %)
0 diff
(100 %id)
DW415383 Liver .i 612 to 908 17 to 313       297/313
(94 %)
6 diff
(98.1 %id)
AI659093 Prostate .i 612 to 1069 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW148936 Kidney, renal cell tumor .i 616 to 1069 455 to 1       455/465
(97 %)
3 diff
(99.4 %id)
FN140774 breast carcinoma .i 618 to 713 93 to 1     Submitted on the opposite strand 93/93
(100 %)
3 diff
(96.8 %id)
BQ001882 lung, Metastatic Chondrosarcoma .i 628 to 1069 460 to 19   AAA   442/442
(100 %)
6 diff
(98.7 %id)
BF368634 placenta_normal .i 629 to 995 361 to 5       357/361
(98 %)
0 diff
(100 %id)
BM679947 eye, fetal eye .i 638 to 1069 450 to 19   AAA   432/432
(100 %)
6 diff
(98.7 %id)
AA076648 Pancreas .i 639 to 1072 442 to 6       437/442
(98 %)
0 diff
(100 %id)
AA948654 2 pooled tumors (clear cell type), Kidney .i 642 to 1069 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AW579152 denis_drash .i 646 to 1009 370 to 7       364/370
(98 %)
4 diff
(99.0 %id)
AI816836 2 pooled tumors (clear cell type), Kidney .i 650 to 1072 426 to 4       423/426
(99 %)
0 diff
(100 %id)
AA480567   .i 652 to 1037 1 to 386       386/386
(100 %)
3 diff
(99.3 %id)
AA196507   .i 653 to 912 261 to 1       261/261
(100 %)
5 diff
(98.1 %id)
BU786959 insulinoma, Pancreas .i 653 to 1066 414 to 1   fully sequenced,   414/414
(100 %)
0 diff
(100 %id)
BU073426 insulinoma, Pancreas .i 654 to 1069 431 to 16   fully sequenced, AAA   416/416
(100 %)
0 diff
(100 %id)
BU782828 insulinoma, Pancreas .i 656 to 1069 430 to 17   fully sequenced, AAA   414/414
(100 %)
0 diff
(100 %id)
AI269330 Kidney .i 661 to 1070 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
AI521537 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 661 to 1072 414 to 3       412/414
(99 %)
0 diff
(100 %id)
AA622922 lung, lung tumor .i 676 to 1071 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA774260 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 678 to 1195 1 to 520   tiling clone,   520/520
(100 %)
11 diff
(97.9 %id)
TI_1948071981   .i 685 to 876 331 to 140     Submitted on the opposite strand 192/220
(87 %)
0 diff
(100 %id)
BM670245 eye, lens .i 688 to 1069 400 to 19   fully sequenced, AAA   382/382
(100 %)
0 diff
(100 %id)
AW793476 uterus .i 690 to 1025 19 to 354       336/354
(94 %)
6 diff
(98.4 %id)
AI399702 Prostate .i 690 to 1069 380 to 1       380/380
(100 %)
0 diff
(100 %id)
CB117509 Liver .i 691 to 992 1 to 302       302/302
(100 %)
3 diff
(99.1 %id)
TI_149276253   .i 699 to 1069 455 to 85   AAA   371/958
(38 %)
1 diff
(99.9 %id)
BU677034 lung, Primary Lung Epithelial Cells .i 699 to 1069 389 to 19   AAA   371/379
(97 %)
1 diff
(99.8 %id)
AA058712 uterus .i 700 to 1069 372 to 1   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
AA576101 breast, breast tumor .i 702 to 1068 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AA569664   .i 703 to 1074 380 to 9       372/380
(97 %)
0 diff
(100 %id)
AI972459 Prostate .i 714 to 1072 361 to 3       359/361
(99 %)
0 diff
(100 %id)
AI972734 Prostate .i 714 to 1072 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AI520912 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 716 to 1069 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
AA523985 colon .i 722 to 1069 365 to 18   AAA   348/348
(100 %)
0 diff
(100 %id)
AI028314   .i 729 to 1072 346 to 3       344/346
(99 %)
0 diff
(100 %id)
AW008326 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 734 to 1069 367 to 32   AAA   336/336
(100 %)
6 diff
(98.3 %id)
AA424005   .i 735 to 1061 12 to 337       326/337
(96 %)
6 diff
(98.3 %id)
AA445963   .i 738 to 1065 1 to 328   fully sequenced,   328/328
(100 %)
0 diff
(100 %id)
AA775069 ovary .i 738 to 1071 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AA594894 normal prostate, Prostate .i 740 to 1061 333 to 13       321/333
(96 %)
0 diff
(100 %id)
AW512854 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .i 750 to 1072 326 to 4       323/326
(99 %)
0 diff
(100 %id)
AA225026   .i 751 to 1072 322 to 1       322/333
(96 %)
0 diff
(100 %id)
AI804752 Prostate .i 758 to 1070 313 to 1       313/313
(100 %)
0 diff
(100 %id)
EC545655 Prostate .i 785 to 900 1 to 116       116/116
(100 %)
0 diff
(100 %id)
AA469331   .i 791 to 1069 290 to 12   AAA   279/279
(100 %)
1 diff
(99.7 %id)
AA569662   .i 800 to 1079 283 to 4       280/283
(98 %)
0 diff
(100 %id)
AA225628   .i 801 to 907 279 to 390       355/390
(91 %)
12 diff
(97.0 %id)
AA622422 Prostate, prostate tumor .i 802 to 1069 308 to 41   AAA   268/268
(100 %)
0 diff
(100 %id)
AI652020 pooled germ cell tumors .i 802 to 1069 268 to 1       268/268
(100 %)
0 diff
(100 %id)
EC547550 Prostate .i 816 to 925 1 to 107       107/107
(100 %)
3 diff
(97.2 %id)
AA676472   .i 820 to 1175 381 to 26   AAA   356/356
(100 %)
0 diff
(100 %id)
CA415102 Chondrosarcoma Grade II, Left Pelvis .i 830 to 1069 258 to 19   AAA   240/248
(96 %)
0 diff
(100 %id)
AA758925   .i 832 to 1072 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AL037508 brain .i 835 to 1069 21 to 255   AAA   235/255
(92 %)
5 diff
(98.1 %id)
AI630675 blood .i 836 to 1070 265 to 31   AAA   235/235
(100 %)
1 diff
(99.6 %id)
FN092100 breast carcinoma .i 843 to 950 1 to 104       104/105
(99 %)
5 diff
(95.3 %id)
AI054154 ovary, papillary serous carcinoma .i 846 to 1068 244 to 22   AAA   223/244
(91 %)
2 diff
(99.2 %id)
AI054034 ovary, papillary serous carcinoma .i 846 to 1063 236 to 19   AAA   218/239
(91 %)
1 diff
(99.6 %id)
AI266080 lung .i 846 to 1068 22 to 244     Submitted on the opposite strand 223/287
(77 %)
2 diff
(99.4 %id)
AI284812 breast, invasive carcinoma .i 846 to 1069 13 to 236   AAA   224/236
(94 %)
6 diff
(97.5 %id)
AI252034 ovary, papillary serous carcinoma .i 846 to 1069 13 to 236   AAA Submitted on the opposite strand 224/236
(94 %)
6 diff
(97.5 %id)
AI306761 breast, breast carcinoma in situ .i 846 to 1063 24 to 242   AAA Submitted on the opposite strand 219/242
(90 %)
6 diff
(97.6 %id)
AI307511 bone marrow, stem cell 34+/38+ .i 846 to 1069 13 to 236   AAA Submitted on the opposite strand 224/236
(94 %)
6 diff
(97.5 %id)
AI349919 brain, oligodendroglioma .i 846 to 1072 13 to 239     Submitted on the opposite strand 227/254
(89 %)
2 diff
(99.3 %id)
AI435686 adenocarcinoma, breast .i 846 to 1019 34 to 207     Submitted on the opposite strand 174/207
(84 %)
6 diff
(97.2 %id)
AI612061 bone marrow, CD34+, CD38- from normal bone marrow donor .i 846 to 1070 13 to 237   AAA Submitted on the opposite strand 225/237
(94 %)
6 diff
(97.5 %id)
AI611472 bone marrow, CD34+, CD38- from normal bone marrow donor .i 846 to 1068 24 to 244   AAA Submitted on the opposite strand 221/244
(90 %)
6 diff
(97.6 %id)
AI611412 bone marrow, CD34+, CD38- from normal bone marrow donor .i 846 to 1068 13 to 235   AAA Submitted on the opposite strand 223/235
(94 %)
6 diff
(97.5 %id)
AI590462 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .i 846 to 1069 13 to 237   AAA Submitted on the opposite strand 225/237
(94 %)
6 diff
(97.5 %id)
AW075185 bone marrow, stem cell 34+/38+ .i 846 to 1069 24 to 247   AAA Submitted on the opposite strand 224/247
(90 %)
6 diff
(97.6 %id)
AW268089 invasive adenocarcinoma, lung .i 846 to 1063 13 to 230   AAA Submitted on the opposite strand 218/230
(94 %)
6 diff
(97.4 %id)
BF718552 epidermis, skin .i 852 to 1069 218 to 1       218/218
(100 %)
0 diff
(100 %id)
BF718560 epidermis, skin .i 852 to 1066 219 to 3       217/219
(99 %)
0 diff
(100 %id)
FN053310 breast carcinoma .i 862 to 966 1 to 108       108/115
(93 %)
4 diff
(96.6 %id)
AA430016   .i 903 to 1069 183 to 17   fully sequenced, AAA   167/167
(100 %)
0 diff
(100 %id)
AI537037 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i 922 to 1069 187 to 40   AAA   148/148
(100 %)
4 diff
(97.3 %id)
FN153861 breast carcinoma .i 963 to 1024 65 to 2     Submitted on the opposite strand 64/66
(96 %)
0 diff
(100 %id)
BM669085 eye, lens .i 971 to 1069 117 to 19   fully sequenced, AAA   99/99
(100 %)
0 diff
(100 %id)
FN083736 breast carcinoma .i 973 to 1070 1 to 97       97/98
(98 %)
2 diff
(98.0 %id)
AA225496   .i 980 to 1069 102 to 12   AAA   91/91
(100 %)
1 diff
(99.0 %id)
FN154245 breast carcinoma .i 993 to 1071 80 to 2     Submitted on the opposite strand 79/80
(98 %)
0 diff
(100 %id)
BM672854 eye, optic nerve .i 994 to 1069 94 to 19   fully sequenced, AAA   76/76
(100 %)
0 diff
(100 %id)
TI_57239667   .j 1 to 782 22 to 805 exact tiling clone,   784/806
(97 %)
11 diff
(98.7 %id)
BI916149 brain .j 7 to 782 1 to 778 exact tiling clone,   778/779
(99 %)
5 diff
(99.4 %id)
Z36792 Pancreas .k 1 to 401 1 to 398   tiling clone,   398/400
(99 %)
13 diff
(96.8 %id)
AY885169 brain Gene TCEAL4, variant not shown         This clone was ignored    
CD705888 normal nasopharynx Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
AL535343.
matches multiple genes
brain, fetal brain Gene zawda, variant not shown         This clone was ignored, also hits gene zawda    
AL535343.
matches multiple genes
brain, fetal brain Gene TCEAL4, variant not shown         This clone was ignored, also hits gene zawda    
AL565881.
matches multiple genes
brain, fetal brain Gene zawda, variant not shown         This clone was ignored, also hits gene zawda    
AL565881.
matches multiple genes
brain, fetal brain Gene TCEAL4, variant not shown         This clone was ignored, also hits gene zawda    
AV694488 hepatocellular carcinoma Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
AV654466 corresponding non cancerous liver tissue Gene TCEAL4, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BE734195 choriocarcinoma, placenta Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
BF695070 muscle (skeletal) Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
BQ014044 Chondrosarcoma, Left Pubic Bone Gene TCEAL4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CF595629 Stomach, adenocarcinoma Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
DR423089 eye, Pterygium Gene TCEAL4, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149292321   Gene TCEAL4, variant not shown         This clone was ignored    
BM974516 lung Gene TCEAL4, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f, .g, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI